Vaxcyte (PCVX) Other Non-Current Assets (2019 - 2026)

Vaxcyte (PCVX) has 8 years of Other Non-Current Assets data on file, last reported at $1.5 million in Q1 2026.

• On a quarterly basis, Other Non-Current Assets rose 11.14% year-over-year to $1.5 million in Q1 2026; TTM through Mar 2026 was $1.5 million, a 11.14% increase from a year earlier, with the FY2025 full-year figure at $1.5 million, up 11.31% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $1.5 million, roughly flat from $1.5 million in the prior quarter.
• Over the last five years, Other Non-Current Assets for PCVX reached as high as $5.7 million in Q1 2022 and fell as low as $871000.0 in Q3 2022.
• Historically, Other Non-Current Assets has averaged $1.8 million across 5 years, with a median of $1.3 million in 2024.
• Across the five-year window, Other Non-Current Assets soared 523.31% in 2022 and tumbled 84.63% in 2023, its largest moves.
• Year by year, Other Non-Current Assets stood at $871000.0 in 2022, then advanced by 26.64% to $1.1 million in 2023, then rose by 19.4% to $1.3 million in 2024, then advanced by 11.31% to $1.5 million in 2025, then changed by 0.0% to $1.5 million in 2026.
• Per Business Quant data, the three most recent Other Non-Current Assets figures were $1.5 million in Q1 2026, $1.5 million in Q4 2025, and $1.5 million in Q3 2025.